Hamilton COVID-19 Biorepository, Canada

Registration Status: Completed

Objective: The Hamilton COVID-19 Biorepository (HCB) has been established to collect, curate, store, and distribute high quality biospecimens for research purposes. Biospecimens will be obtained from individuals tested for COVID-19 in the Hamilton, Ontario region. The majority of samples will be from individuals with a diagnosis of COVID-19.

Registered Biobank Name Hamilton COVID-19 Biorepository
Biobank Leader Dr. Mark Larché
Country Canada
Email for biobank inquiries larche@mcmaster.ca
Principal Investigator Dr. Mark Larché, Dr. Guillaume Paré
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: